The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter randomized controlled trial to evaluate the efficacy of surgery vs. radiofrequency ablation for small hepatocellular carcinoma (SURF trial).
 
Namiki Izumi
No Relationships to Disclose
 
Kiyoshi Hasegawa
No Relationships to Disclose
 
Yujiro Nishioka
No Relationships to Disclose
 
Tadatoshi Takayama
No Relationships to Disclose
 
Naoki Yamanaka
No Relationships to Disclose
 
Masatoshi Kudo
Honoraria - Abbvie; Astellas Pharma; Chugai Pharma; Daiichi Sankyo; EA Pharma; Eisai; Gilead Sciences; MSD; Otsuka; Taiho Pharmaceutical
Consulting or Advisory Role - Bayer; Eisai; MSD
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb Japan (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Otsuka (Inst); Taiho Pharmaceutical (Inst)
 
Mitsuo Shimada
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); Bayer Yakuhin (Inst); Chugai Pharma (Inst); Covidien (Inst); CSL Behring (Inst); Eisai (Inst); Japan Blood Products Organization (Inst); Johnson & Johnson (Inst); Lilly (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); TSUMURA & CO. (Inst)
 
Masahumi Inomata
No Relationships to Disclose
 
Shuichi Kaneko
No Relationships to Disclose
 
Hideo Baba
Honoraria - Lilly; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Chugai Pharma (Inst); Johnson & Johnson (Inst); Lilly (Inst); Merck Serono (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Yakult Honsha (Inst)
 
Kazuhiko Koike
No Relationships to Disclose
 
Masao Omata
No Relationships to Disclose
 
Masatoshi Makuuchi
No Relationships to Disclose
 
Yutaka Matsuyama
No Relationships to Disclose
 
Norihiro Kokudo
No Relationships to Disclose